Immunomodulation by iap inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/437 (2006.01)

Patent

CA 2724720

The present invention is directed to immune adjuvants containing IAP inhibitors, including Smac mimetics. The invention further provides pharmaceutical compositions and vaccines containing an IAP inhibitor and an antigen. Methods of enhancing an immune response by administration of an IAP inhibitor, methods of treating or preventing cancer, methods of treating or preventing infections, methods of treating autoimmune disorders, and methods of potentiating cytokine or antibody production are also provided.

La présente invention concerne des adjuvants immunitaires contenant des inhibiteurs dIAP, comprenant des mimétiques de Smac. Linvention concerne en outre des compositions pharmaceutiques et des vaccins contenant un inhibiteur dIAP et un antigène. La présente invention concerne en outre des procédés damélioration dune réponse immunitaire par administration dun inhibiteur dIAP, des procédés  de traitement ou de prévention du cancer, des procédés de traitement ou de prévention des infections, des procédés de traitement de troubles auto-immuns, et des procédés de potentialisation de la production de cytokine ou danticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunomodulation by iap inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunomodulation by iap inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulation by iap inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1379702

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.